Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention

Blood

Volumn 84, Issue 4, 1994, Pages 1328-1332

  Sayer, H G ^b   Longton, G ^b   Bowden, R ^b   Pepe, M ^b   Storb, R ^a  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BACTEREMIA; CANDIDA ALBICANS; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FUNGEMIA; GRAFT VERSUS HOST REACTION; GRAM POSITIVE BACTERIUM; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; STREPTOCOCCUS;

EID: 0028065443     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v84.4.1328.1328     Document Type: Article

References (26)

1. Doney KC, Weiden PL, Storb R, Thomas ED: Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 11:1, 1981
2. Yau JC, LeMaistre CF, Zagars GK, Williams LA, Meneghetti CM, Luke DR, Dunphy FR, Spinolo JA, Jagannath S, Spitzer G, Zander AR. Dicke KA: Methylprednisone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease. Bone Marrow Transplant 5:269, 1990
3. Forman SJ, Blume KG, Krance RA, Miner PJ, Metter GE, Hill LR, O'Donnell MR, Nademanee AP, Snyder DS: A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: Methotrexate/prednisone v cyclosporine A/prednisone. Transplant Proc 19:2605, 1987
4. Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Huyden GB, Burns WH, Farmer ER. Hess AD, Kaizer H, Mellits D, Sensenbrenner LL, Stuart R, Yeager AM: Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: A randomized double-blind study in patients undergoing allogeneic marrow transplantation. Clin Transplant 1:21, 1987
5. Storb R, Pepe M, Anasetti C, Appelbaum FR, Beatty P, Doney K, Martin P, Stewart P, Sullivan KM, Witherspoon R, Bensinger W, Buckner CD, Clift R, Hansen J, Longton G, Loughran T, Petersen FB, Singer J, Sanders J, Thomas ED: What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 76:1037, 1990
6. Winston DJ, Gale RP, Meyer DV, Young LS, and the UCLA Bone Marrow Transplantation Group: Infectious complications of human bone marrow transplantation. Medicine 58:1, 1979
7. Meyers JD: Infection in bone marrow transplant recipients. Am J Med 81:27, 1986 (suppl 1A)
8. Witherspoon RP: Suppression and recovery of immunologic function after bone marrow transplantation. J Natl Cancer Inst 76:1321, 1986
9. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
10. Sullivan KM. Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, Counts GW, Bowden RA, Petersen FB, Witherspoon RP, Budinger MD, Schwartz RS, Appelbaum FR, Clift RA, Hansen JA, Sanders JE, Thomas ED, Storb R: Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323:705, 1990
11. Petersen F, Thornquist M, Buckner C, Counts G, Nelson N, Meyers J, Clift R, Thomas E: The effects of infection prevention regimens on early infectious complications in marrow transplant patients: A four arm randomized study. Infection 16:199, 1988
12. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
13. Ramlau-Hansen H: Smoothing counting process intensities by means of kernel functions. Ann Stat 11:453, 1983
14. Pepe MS, Longton GM, Pettinger M, Mori M, Fisher LD, Storb R: Summarizing data on survival, relapse and chronic-graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods. Br J Haematol 83:602, 1993
15. Kalbfieish JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
16. Pepe MS, Mori M: Kaplan-Meier, marginal, or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737, 1993
17. Fauci AS, Dale DC: The effect of hydrocortisone on the kinetics of normal human lymphocytes. Blood 46:235, 1975
18. Strom TB: Immunosuppression in tissue and organ transplantation, in Brent L, Sells RA (eds): Organ Transplantation: Current Clinical and Immunological Concepts. London, UK, Bailliere Tindall, 1989, p 39
19. Flye MW: Immunosuppressive therapy, in Flye MW (ed): Principles of Organ Transplantation. Philadelphia, PA, Saunders, 1989, p 155
20. Cupps TR, Fauci AS: Corticosteroid-mediated immunoregulation in man. Immunol Rev 65:133, 1982
21. Stuck AE, Minder CE, Frey FJ: Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11:954, 1989
22. Salaman JR, Griffin PJ: Immunosuppression with a combination of cyclosporin, azathioprine, and prednisolone may be unsafe. Lancet 2:1066, 1985 (letter)
23. van Dorp WT, van Es LA, Thompson J, van der Woude FJ: The effects of a maintenance immunosuppressive protocol after renal transplantation on infectious complications, comparing cyclosporine/prednisone, cyclosporine/azathioprine/prednisone, and conversion. Transplant 51:193, 1991
24. Meyers JD: Infections in marrow transplant recipients, in Mandell GL, Douglas RG Jr, Bennett JE (eds): Principles and Practices of Infectious Diseases. New York, NY, Churchill Livingston, 1990, p 2291
25. Sosa R, Weiden PL, Storb R, Syrotuck J, Thomas ED: Granulocyte function in human allogeneic marrow graft recipients. Exp Hematol 8:1183, 1980
26. Clark RA, Johnson FL, Klebanoff SJ, Thomas ED: Defective neutrophil chemotaxis in bone marrow transplant patients. J Clin Invest 58:22, 1976